Market Overview

Benzinga's M&A Chatter for Monday November 23, 2015

Share:

The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday November 23, 2015:

Diebold Offers to Acquire Wincor Nixdorf for €38.98/Share in Cash Plus 0.434 Deibold Shares

The Deal:
Diebold, Incorporated (NYSE: DBD) and Wincor Nixdorf AG (OTC: WNXDF) announced Monday, that Diebold will launch a voluntary public tender offer to all shareholders of Wincor Nixdorf. Under the terms of the agreement, Diebold will offer Wincor Nixdorf shareholders €38.98 in cash plus 0.434 Diebold common shares per Wincor Nixdorf share, valuing Wincor Nixdorf at approximately $1.8 billion, including debt.

Diebold shares fell 6.69% Monday, closing at $35.00.

Comtech Reports to Acquire TeleComm Systems for $5.00/Share in Cash

The Deal:
Comtech Telecommunications Corp. (NASDAQ: CMTL) and TeleCommunication Systems, Inc. (NASDAQ: TSYS) announced Monday a definitive merger agreement under which Comtech will acquire TCS for $5.00 per share in cash via a tender offer, for an enterprise value of approximately a $430.8 million. The deal is expected to close no later than March 2016.

TeleCommunication Systems rose 12.5% Monday, closing at $4.94.

Pfizer to Acquire Allergan in $150B Deal

The Deal:
Pfizer Inc. (NYSE: PFE) and Allergan plc (NYSE: AGN) announced Monday, that the companies have entered into, a definitive merger agreement under which Pfizer will merge with Allergan in a stock transaction valued at $363.63 per Allergan share, for a total enterprise value of approximately $160 billion. Under the agreement, Allergan shareholders will receive 11.3 shares of the combined company for each Allergan shares, while Pfizer shareholders will receive one share of the combined company for each Pfizer share.

The transaction is expected to be completed in H2 of 2016.

Allergan fell 3.5% Monday, closing at $301.72. Pfizer fell 2.64% to close at $31.33.

Posted-In: M&A News Rumors Movers

 

Related Articles (CMTL + AGN)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Palo Alto Networks Beats Q1 Views, Shares Gain

XBiotech Provides Update on Phase III Oncology Study in Europe